Laser GaAlAs (λ860nm) photobiomodulation for the treatment of bisphosphonate-induced osteonecrosis of the jaw

Photomedicine and Laser Surgery

Volumn 30, Issue 5, 2012, Pages 293-297

  Da Guarda, Milena Góes ^a   Paraguassú, Gardênia Matos ^a   Cerqueira, Naiadja Santana ^a   Cury, Patrícia Ramos ^a   Farias, Jener Gonçalves ^b   Ramalho, Luciana Maria Pedreira ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Dental School   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; BISPHOSPHONATES; BONE NECROSIS; CONTINUOUS WAVE; ENERGY DENSITY; LOW LEVEL LASER THERAPY; ORAL MUCOSA; OSTEONECROSIS; PHOTOBIOMODULATION; PUNCTUAL CONTACTS; QUALITY OF LIFE; SPOT SIZES; THERAPEUTIC PROTOCOLS; TISSUE HEALING; TOOTH EXTRACTION; TREATMENT MODALITY; WOUND HEALING;

ALUMINUM GALLIUM ARSENIDE; ANTIBIOTICS; BONE; LASER SURGERY; TISSUE;

PATIENT TREATMENT;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIODE LASER; HUMAN; JAW DISEASE; JAW OSTEONECROSIS; LOW LEVEL LASER THERAPY; MALE;

AGED, 80 AND OVER; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; HUMANS; JAW DISEASES; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; MALE;

EID: 84860532000     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2011.3219     Document Type: Article

References (37)

1. Khosla, S., Burr, D., Cauley, J., et al (2007). Bisphosphonateassociated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22, 1479-1491.
2. Gegler, A., Cherubini, K., Figueiredo, M.A.S., Yurgel, L.S., and Azambuja, A.A. (2006). Bisfosfonatos e osteonecrose maxilar: Revisão da literatura e relato de dois casos. Rev. Bras. Cancerologia 52, 25-31.
3. Drake, M.T., Clarke, B.L., and Khosla, S. (2008). Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin. Proc. 83, 1032-1045.
4. Ruggiero, S.L. (2009). Bisphosphonates-related osteonecrosis of the jaw (BRONJ): Initial discovery and subsequent development. J. Oral Maxillofac. Surg. 67, 13-18.
5. Ruggiero, S.L., Dodson, T.B., Assael, L.A., Landesberg, R., Marx, R.E., and Mehrotra, B. (2009). American Association of Oral and Maxillofacial Surgeons. Task Force on Bisphosphonate-Related Osteonecrosis of the Jaw. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw. Available at: http://www.aaoms.org/docs/position-papers/bronj-update.pdf. Accessed May 2011.
6. Gerbi, M.E., Marques, A.M., Ramalho, L.M., et al. (2008). Infrared laser light further improves bone healing when associated with bone morphogenic proteins: An in vivo study in a rodent model. Photomed. Laser Surg. 26, 55-60.
7. Márquez Martínez, M.E., Pinheiro, A.L., and Ramalho, L.M. (2008). Effect of IR laser photobiomodulation on the repair of bone defects grafted with organic bovine bone. Lasers Med.Sci. 23, 313-317.
8. Pinheiro, A.L. (2009). Advances and perspectives on tissue repair and healing. Photomed Laser Surg. 27, 833-836.
9. Ga' l.P., Mokry', M., Vidinsky', B., et al. (2009). Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635nm on open skin wound healing in normal and corticosteroid- Treated rats. Lasers Med. Sci. 24, 539-547.
10. Ga' l.P., Vidinsky', B., Toporcer, T., et al. (2006). Histological assessment of the effect of laser irradiation on skin wound healing in rats. Photomed. Laser Surg. 24, 480-484.
11. Ozcelik, O., Cenk Haytac, M., Kunin, A., and Seydaoglu, G. (2008). Improved wound healing by low-level laser irradiation after gingivectomy operations: A controlled clinical pilot study. J. Clin. Periodontol. 35, 250-254.
12. Amorim, J.C., de Sousa, G.R., de Barros Silveira, L., Prates, R.A., Pinotti, M., and Ribeiro, M.S. (2006). Clinical study of the gingiva healing after gingivectomy and low-level laser therapy. Photomed. Laser Surg. 24, 588-594.
13. Markovic, A., and Todorovic, L.J. (2007). Effectiveness of dexamethasone and low-power laser in minimizing oedema after third molar surgery: A clinical trial. Int. J. Oral Maxillofac. Surg. 36, 226-229.
14. Antunes, H.S., de Azevedo, A.M., da Silva Bouzas, L.F., et al. (2007). Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: A randomized trial. Blood 109, 2250-2255.
15. Scoletta, M., Arduino, P.G., Reggio, L., Dalmasso, P., and Mozzati, M. (2010). Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: Preliminary results of a prospective study. Photomed. Laser Surg. 28, 179-184.
16. Romeo, U., Galanakis, A., Marias, C., et al. (2011). Observation of pain control in patients with bisphosphonateinduced osteonecrosis using low level laser therapy: Preliminary results. Photomed. Laser Surg. 29, 447-452.
17. Scarpa, L.C., Leite, L.C.M., Lacerda, J.C.T., and Arantes, D.C.B. (2010). Osteonecrose nos ossos da maxila e mandí-bula associada ao uso de bifosfonato de só dio. Rev. Bras. Pesq. Saúde. 12, 86-92.
18. Dearnaley, D.P., Sydes, M.R., Mason, M.D., et al. (2003). A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J. Natl. Cancer Inst. 95, 1300-1311.
19. Pinheiro, A.L.B., and Gerbi, M.E.M.M. (2006). Photoengineering of bone repair processes. Photomed. Laser Surg. 24, 169-178.
20. Vescovi, P., Merigo, E., Manfredi, M., et al (2008). Nd:YAG laser biostimulation in the treatment of bisphosphonateassociated osteonecrosis of the jaw: Clinical experience in 28 cases. Photomed. Laser Surg. 26, 37-46.
21. Blaya, D.S., Guimarães, M.B., Pozza, D.H., Weber, J.B.B., and de Oliveira, M.G. (2008). Histologic study of the effect of laser therapy on bone repair. J. Contemp. Dent Pract. 9, 041-048.
22. Nissan, J., Assif, D., Gross, D., Yaffe, A., and Binderman, I. (2006). Effect of low intensity laser irradiation on surgically created bony defects in rats. J. Oral Rehabil. 33, 619-624.
23. Merli, L.A., Santos, M.T., Genovese, W.J., and Faloppa, F. (2005). Effect of low-intensity laser irradiation on the process of bone repair. Photomed. Laser Surg. 23, 212-215.
24. García-Sáenz, J.A., Ló pez-Tarruella, S., García-Paredes, B., Rodríguez-Lajusticia, L., Villalobos, L., and Díaz-Rubio, E. (2007). Osteonecrosis of the jaw as an adverse bisphosphonate event: Three cases of bone metastatic prostate cancer patients treated with zoledronic acid. Med. Oral Patol. Oral Cir. Bucal. 12, 351-356.
25. Fantasia, J.E. (2009). Biphosphonates-what the dentist needs to know: Practical considerations. J. Oral Maxillofac. Surg. 67, 53-60.
26. Ruggiero, S.L., Mehrotra, B., Rosenberg, T.J., and Engroff, S.L. (2004). Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J. Oral Maxillofac. Surg. 62, 527-534.
27. Sousa, F.R.N., and Jardim Júnior, E.G. (2008). Osteonecrose associada com o uso dos Bifosfonatos. Pesqui. Bras. Odontopediatria Clin. Integr. 8, 375-380.
28. Capsoni, F., Longhi, M., and Weinstein, R. (2006). Bisphosphonate- associated osteonecrosis of the jaw: The rheumatologist's role. Arthritis Res. Ther. 8, 1-6.
29. Durie, B.G.M. (2009). Concise Review of the Disease and Treatment Options. International Myeloma Foundation Latin America, 4-39.
30. Fournier, P., Boissier, S., Filleur, S., et al (2002). Bisphosphonates inhibit angiogenesis in vitro and testosteronestimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 62, 6538-6544.
31. Wood, J., Bonjean, K., Ruetz, S., et al (2002). Novel antiangiogenic effects of the bisphosphonates compound zoledronic acid. J Pharmacol Exp Ther. 302, 1055-1061.
32. Melo, A.C., Bastos, M., Bastos, M.R., Loureiro, A.S., and Araújo, S.S. (2005). Jaw osteonecrosis in a patient suffering from multiple myeloma-pathology secondary to pamidronate therapy. Rev. Bras. Hematol. Hemoter. 27, 221-222.
33. Burr, D.B., and Allen, M.R. (2009). Mandibular necrosis in beagle dogs treated with bisphosphonates. Orthod. Craniofac. Res. 12, 221-228.
34. Sarin, J., DeRossi, S., and Akintoye, S. (2008). Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis. 14, 277-285.
35. Gliklich, R., and Wilson, J. (2009). Epidemiology of bisphosphonate- related osteonecrosis of the jaws: The utility of a national registry. J. Oral Maxillofac. Surg. 67, 71-74.
36. Souza, L.N., Souza, A.C.R.A., Mari, V.F.A., Borges, A.P.N., and Alvarenga, R.L. (2009). Osteonecrosis of the jaws associated with the use of biphosphonates: Literature review and case study presentation. Rev. Port. Estomatol. Cir. Maxilofac. 50, 229-236.
37. Romeo, U., Galanakis, A., Marias, C., et al (2011). Observation of pain control in patients with bisphosphonatesinduced osteonecrosis using low-level laser therapy: Preliminary results. Photomed. Laser Surg. 29, 447-452.